Thoracic aortic aneurysm management

🧬 Pathophysiology - The Wall Weakens

The aortic wall weakens from degradation of structural proteins (elastin, collagen), leading to dilation. Governed by Laplace's Law, wall tension increases with radius ($T = P \times r$), promoting further expansion.

• Degenerative (Most Common):
  • Atherosclerosis: Chronic inflammation damages intima and media.
  • Cystic Medial Necrosis: Fragmentation of elastic fibers in the media; common with aging.
• Genetic/Connective Tissue Disorders:
  • Marfan Syndrome: Defective fibrillin-1 (FBN1).
  • Ehlers-Danlos Syndrome (Vascular): Defective type III collagen.
• Other:
  • Infections: Syphilitic aortitis, mycotic aneurysms (Staph, Salmonella).
  • Trauma: Deceleration injury.

⭐ Marfan syndrome is classically associated with cystic medial necrosis, predisposing to aortic root aneurysm and dissection.

🤫 Clinical Manifestations - The Silent Threat

Most are asymptomatic and discovered incidentally. When symptoms occur, they are due to expansion, compression, or rupture.

• Pain: Most common symptom. Typically a deep, steady, severe pain in the chest or back.
• Compression of adjacent structures:
  • Hoarseness: Left recurrent laryngeal nerve palsy.
  • Dysphagia: Esophageal compression.
  • Stridor/Cough: Tracheal or mainstem bronchus compression.
  • SVC Syndrome: Edema of the face/neck/arms, JVD.

⭐ Hoarseness from a TAA is a classic sign of left recurrent laryngeal nerve compression (Ortner's syndrome), a frequently tested association.

🩺 Diagnosis - Seeing the Bulge

• Initial Test: Chest X-ray (CXR) is often the first clue, showing a widened mediastinum or an enlarged aortic knob.
• Gold Standard: CT Angiography (CTA) is the definitive diagnostic tool.
  • Details aneurysm size, location, and branch vessel involvement.
  • Essential for pre-operative planning (Open vs. TEVAR).
• Alternatives:
  • MRA: For stable patients with contraindications to CTA (e.g., severe contrast allergy, renal failure).
  • TEE: Useful for unstable patients or intra-operative assessment.

⭐ CTA is not just for diagnosis; it's the essential roadmap for planning repair, determining suitability for endovascular (TEVAR) vs. open surgery.

🔪 Management - Cut or Watch?

• Medical Management (Watch): Goal is to ↓ aortic wall stress & slow expansion.
  • BP Control: Target SBP 100-120 mmHg.
  • Agents: β-blockers (first-line); ARBs (especially for Marfan syndrome).
  • Surveillance: Serial imaging (CT/MRI) every 6-12 months.

⭐ Beta-blockers are key as they decrease the rate of change of blood pressure ($dP/dt$), reducing aortic shear stress beyond just lowering the absolute BP.

• Surgical Intervention (Cut): Decision based on size, growth rate, or symptoms.

💥 Complications - When the Wall Breaks

• Rupture: Catastrophic hemorrhage (hemothorax, hemopericardium).
  • Presents with sudden pain, profound hypotension, and shock.
• Dissection: Intimal tear creates a false lumen.
  • Presents with new, severe, "tearing" chest or back pain.
  • Leads to malperfusion syndromes (stroke, MI, limb ischemia).

⭐ Rupture is a surgical catastrophe with pre-hospital mortality >80%. Immediate intervention is the only chance for survival.

⚡ Biggest Takeaways

• Ascending TAA is linked to Marfan syndrome and cystic medial necrosis; descending TAA to atherosclerosis.
• Often asymptomatic; symptoms from compression (hoarseness, dysphagia) or chest/back pain.
• CT angiography (CTA) is the diagnostic gold standard for planning repair.
• Repair ascending TAA at >5.5 cm (or >4.5 cm in Marfan).
• Repair descending TAA at >6.0 cm, often with endovascular repair (TEVAR).
• Medical therapy: strict blood pressure control with beta-blockers to slow growth.